Among more than 5,000 reproductive age women, 66.4% had one or more known modifiable risk factors, with this percentage ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...

"The Mediterranean diet, rich in fiber, whole grains, antioxidants, and anti-inflammatory compounds, is known to reduce ...

Moderate-to-severe traumatic brain injury (TBI) increased malignant brain tumor risk in a large retrospective study of ...

A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to ...

Across 99 studies examining the effects of high-concentration THC products on mental health outcomes, 70% of the ...

The Alliance for Natural Health joined Xlear in a separate petition in May demanding that the FTC drop its requirement for ...

HHS has moved to strip thousands of federal health agency employees of their collective bargaining rights, according to a ...

The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).